Syndax Pharmaceuticals Inc (SNDX)
Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in the development of cancer therapies. Its product candidates include SNDX-5613 and SNDX-6352. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in Waltham, MA.
Address
35 GATEHOUSE DRIVE
WALTHAM, MA 02451
Founded
2005
Number of Employees
184
Website
http://www.syndax.com
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)